Aktiesnakken — Juni 2013
-
Der er lidt baggrund om thyroid / graves disease her http://en.wikipedia.org/wiki/Graves'_disease
-
hvis det kun sælges til kvinder skal prises sættes op
-
også derfor behandling af ovarian kræft er dyrt med prostata kræft er billigt
-
Winkel siger også i meddelelsen, at det ikke påvirker guidance for 2013 - så der er nok ingen milstones
-
Spændende om vi hører noget mere om dette snart igen. Så har vi et til produkt at sætte i pipelinen. Den udvider sig hastigt
-
Kan jeg blive Armensk statsborger
-
min bulgarske kæreste er glad
hun sover på sofaen snart hvis ikke hun holder mund 
-
der er nok milepæl ved opstart af phase III først
-
River Vision Development Corp. was founded by Narrow River Management, LP (Narrow River) for the sole purpose of developing RV001 for GO and other potential indications. The Company is managed under contract with Narrow River, which founds and provides leadership expertise for special purpose drug development companies.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind